Tirzepatide

Product Information

Tirzepatide is a 39-amino acid dual receptor agonist (C225H348N60O68, 5047.61 g/mol) that simultaneously activates GIP and GLP-1 pathways, representing a significant advancement in metabolic research tools. This innovative peptide enhances insulin release, suppresses glucagon secretion, slows gastric emptying, and influences energy metabolism through complementary receptor mechanisms. Research studies demonstrate dose-dependent effects across multiple physiological systems. Laboratory applications focus on glucose metabolism pathways, weight management mechanisms, blood sugar control systems, cardiovascular effects, and kidney function improvements. The dual-action approach provides researchers with insights into synergistic metabolic pathway interactions that single-receptor compounds cannot replicate. Tirzepatide's comprehensive metabolic profile makes it particularly valuable for investigating complex metabolic syndrome mechanisms and multi-system regulatory networks. For laboratory research purposes only.